[1] ULIVI P, ZOLI W, CAPELLI L, et al. Target therapy in NSCLC patients:Relevant clinical agents and tumour molecular characterisation[J].Mol Clin Oncol, 2013, 1(4):575-581. [2] FAES S, DORMOND O. PI3K and AKT:unfaithful partners in cancer[J]. Int J Mol Sci, 2015, 16(9):21138-21152. [3] TUYA N, WANG Y, TONG L, et al. Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway[J]. Exp Ther Med, 2017, 14(6):5767-5772. [4] FU R, YANG P, WU H L, et al. GRP78 secreted by colon cancer cells facilitates cell proliferation via PI3K/Akt signaling[J]. Asian Pac J Cancer Prev, 2014, 15(17):7245-7249. [5] GIFFORD J, HILL R. GRP78 influences chemoresistance and prognosis in cancer[J]. Current Drug Targets, 2018, 19(6):701-708. [6] 王立文, 沈晓洁, 林彬. 非小细胞肺癌中lncRNA MVIH与吉西他滨耐药的相关性研究[J]. 重庆医学, 2017, 46(7):946-948. [7] CHEN Y, HUANG Y, CHEN D M, et al. RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine[J]. OncoTargets Ther, 2018, 11:5579-5589. [8] XU C, YU Y, DING F. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells[J]. Oncol Rep, 2018, 40(1):395-404. [9] XIONG G, HUANG H, FENG M, et al. MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma[J]. J Exp Clin Cancer Res, 2018, 37(1):76-87. [10] WANG Y, SUI Y, YAN K, et al. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance[J]. Oncol Rep, 2015, 33(4):1699-1706. [11] LEE J, YOON Y, LEE S. GRP78 regulates apoptosis, cell survival and proliferation in 5-Fluorouracil-resistant SNUC5 colon cancer cells[J]. Anticancer Res, 2017, 37(9):4943-4951. [12] LIZARDO M, MORROW J, MILLER T, et al. Upregulation of glucose-regulated protein 78 in metastatic cancer cells is necessary for lung metastasis progression[J]. Neoplasia, 2016, 18(11):699-710. [13] WANG Y, WANG J H, ZHANG X L, et al. Endoplasmic reticulum chaperone glucose-regulated protein 78 in gastric cancer:An emerging biomarker[J]. Oncol Lett, 2018, 15(5):6087-6093. [14] DANESHMAND S, QUEK M L, LIN E, et al. Glucose regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival[J]. Hum Pathol, 2007, 38(10):1547-1552. [15] RUI L, GU Y, HE W, et al. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells[J]. Oncotarget, 2017, 8(12):19354-19364. [16] CHIOU J F, TAI C J, HUANG M T, et al. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma[J]. Ann Surg Oncol, 2010, 17(2):603-612. [17] JENIFER B, HUANG W, ZELENIAK A E. Expression of GRP78 master regulator of the unfolded protein response increases chemoresistance in pancreatic ductal adenocarcinoma[J]. Am Associat Cancer Res, 2016, 15(5):1043-1052. [18] ZHANG Z, ZHANG M, LIU H, et al. AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells[J]. J Cell Biochem, 2018, 120(1):756-767. [19] CHEN Y, HUANG W, SUN W, et al. LncRNA MALAT1 promotes cancer metastasis in osteosarcoma via activation of the PI3K-Akt signaling pathway[J]. Cell Physiol Biochem, 2018, 51(3):1313-1326. [20] 胡丽娜, 彭兴春, 郭显智, 等. 抑制Notch和PI3K/Akt信号通路对食管腺癌细胞增殖、侵袭及迁移的影响[J]. 肿瘤防治研究, 2016, 43(8):653-658. [21] ZHENG Z, ZHOU X, CAI Y, et al. TEKT4 promotes papillary thyroid cancer cell proliferation, colony formation, and metastasis through activating PI3K/Akt pathway[J]. Endocr Pathol, 2018, 29(4):310-316. [22] 苏宝安,许之晨,李艾恩.3.0T MR弥散加权成像评价中晚期食管鳞癌放化疗的早期疗效[J].中国医学物理学杂志,2018,35(12):1452-1456. |